Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 46 (HNRNPA1P46) is a human processed pseudogene derived from the HNRNPA1 gene[1][3]. Unlike its parent gene, HNRNPA1P46 does not encode a functional protein product and has no demonstrated functional role or therapeutic relevance. While some pseudogenes may participate in regulatory processes or act as non-coding RNAs, there is no evidence that HNRNPA1P46 is biologically active or clinically significant. Pseudogenes are generally considered non-functional genetic elements, although emerging research shows a minority may be transcribed or have regulatory impacts in certain tissues or diseases, but this is not established for HNRNPA1P46[5].\n\nKey Notes:\n- This gene should not be used as a therapeutic target name or biological marker.\n- If your context demands a functional ribonucleoprotein, the correct entity is *Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1)*, not its pseudogene relatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 46 (HNRNPA1P46).